{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T23:06:28Z","timestamp":1781996788650,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jhepr.2022.100553","type":"journal-article","created":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T01:31:58Z","timestamp":1660440718000},"page":"100553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Survey uncovering variations in the management of primary sclerosing cholangitis across Europe"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6298-9182","authenticated-orcid":false,"given":"Johanna","family":"Eliasson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0252-9341","authenticated-orcid":false,"given":"Bobby","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Chazouilleres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2011-1923","authenticated-orcid":false,"given":"Trine","family":"Folseraas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5114-7799","authenticated-orcid":false,"given":"Ulrich","family":"Beuers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5018-5232","authenticated-orcid":false,"given":"Henriette","family":"Ytting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jhepr.2022.100553_bib1","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis \u2013 a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"10","key":"10.1016\/j.jhepr.2022.100553_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.13774","article-title":"Variations in primary sclerosing cholangitis across the age spectrum","volume":"32","author":"Eaton","year":"2017","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.jhepr.2022.100553_bib3","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3748\/wjg.v21.i6.1956","article-title":"Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis","volume":"21","author":"de Vries","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jhepr.2022.100553_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MEG.0000000000000532","article-title":"Primary sclerosing cholangitis associated with inflammatory bowel disease: an update","volume":"28","author":"Rossi","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jhepr.2022.100553_bib5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mge.2002.125367","article-title":"Increased risk of colorectal neoplasia in patiets with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis","volume":"56","author":"Soetikno","year":"2002","journal-title":"Gastrointest Endosc"},{"issue":"8","key":"10.1016\/j.jhepr.2022.100553_bib6","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weism\u00fcller","year":"2017","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.jhepr.2022.100553_bib7","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/gutjnl-2018-317993","article-title":"British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis","volume":"68","author":"Chapman","year":"2019","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.jhepr.2022.100553_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhepr.2022.100553_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/ajg.2015.112","article-title":"ACG clinical guideline: primary sclerosing cholangitis","volume":"110","author":"Lindor","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jhepr.2022.100553_bib10","article-title":"Management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.jhepr.2022.100553_bib11","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","article-title":"High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study","volume":"129","author":"Olsson","year":"2005","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.jhepr.2022.100553_bib12","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","article-title":"Ursodiol for primary sclerosing cholangitis. Mayo primary sclerosing cholangitis-ursodeoxycholic acid study group","volume":"336","author":"Lindor","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.jhepr.2022.100553_bib13","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhepr.2022.100553_bib14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1478-3231.2007.01441.x","article-title":"Tacrolimus for the treatment of primary sclerosing cholangitis","volume":"27","author":"Talwalkar","year":"2007","journal-title":"Liver Int"},{"issue":"12","key":"10.1016\/j.jhepr.2022.100553_bib15","doi-asserted-by":"crossref","first-page":"943","DOI":"10.7326\/0003-4819-131-12-199912210-00006","article-title":"Combined therapy with azathioprine, prednisolone, and ursodiol in patients with primary sclerosing cholangitis: a case series","volume":"131","author":"Schramm","year":"1999","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.jhepr.2022.100553_bib16","doi-asserted-by":"crossref","DOI":"10.1097\/MEG.0000000000001223","article-title":"Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis","volume":"30","author":"de Chambrun","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jhepr.2022.100553_bib17","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/hep.31560","article-title":"Oral vancomycin, ursodeoxycholic acid, or no therapy for pediatric primary sclerosing cholangitis: a matched analysis","volume":"73","author":"Deneau","year":"2021","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jhepr.2022.100553_bib18","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3748\/wjg.v25.i6.659","article-title":"Cancer risk in primary sclerosing cholangitis: epidemiology, prevention, and surveillance strategies","volume":"25","author":"Fung","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jhepr.2022.100553_bib19","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2020.05.049","article-title":"Effects of primary sclerosing cholangitis on risks of cancer and death in people with inflammatory bowel disease, based on sex, race, and age","volume":"159","author":"Trivedi","year":"2020","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jhepr.2022.100553_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/hep.29730","article-title":"Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis","volume":"67","author":"Ali","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhepr.2022.100553_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/ajg.2011.361","article-title":"Likelihood of malignancy in gallbladder polyps and outcomes following cholecystectomy in primary sclerosing cholangitis","volume":"107","author":"Eaton","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.jhepr.2022.100553_bib22","doi-asserted-by":"crossref","DOI":"10.1007\/BF02049156","article-title":"Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis","volume":"38","author":"Broom\u00e9","year":"1995","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"10.1016\/j.jhepr.2022.100553_bib23","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1055\/s-0043-107029","article-title":"Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline","volume":"49","author":"Aabakken","year":"2017","journal-title":"Endoscopy"},{"issue":"1","key":"10.1016\/j.jhepr.2022.100553_bib24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4254\/wjh.v11.i1.19","article-title":"Treatment of primary sclerosing cholangitis in children","volume":"11","author":"Laborda","year":"2019","journal-title":"World J Hepatol"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555922001252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555922001252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:28:40Z","timestamp":1762900120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555922001252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S2589555922001252"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2022.100553","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survey uncovering variations in the management of primary sclerosing cholangitis across Europe","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2022.100553","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100553"}}